A message from Gary Noon, CEO of Aegate
Gary Noon, CEO of Aegate:
As a company committed to patient safety, Aegate commends the European Union for tackling both the issues of information to patients and patient safety in its consultation findings. Medicine authentication is known to be an effective mechanism to protect patients and legislation that allows patients to receive up-to-date, accurate information on the drugs they are being prescribed, is a positive safety measure.
Only recently, an independent audit of Aegate's authentication system operating in Belgium pharmacies showed it to be 100% accurate in identifying suspicious, recalled and expired products before they are dispensed to patients.
The EU's legislation marks an important and positive turning point in the European pharmaceutical industry. The most important factor now is the speed at which this can be put in place across the European Union. Consequently, we will commit to accelerating the speed of provision of Aegate's authentication service, which is in operation in Belgium, Italy and Greece, to other countries as a result of these findings.
We fully support any initiative that addresses patient safety and look forward to continued collaboration with the industry, government and professional organisations to ensure patients receive the best quality medicines as prescribed.
Aegate's drug authentication service is 100 per cent reliable and effective, corroborates report
Consumers can be protected from receiving counterfeit or substandard pharmaceuticals when their pharmacist is able to authenticate their medicines at the point of dispensing, concludes the world's first audit of a working drug authentication system.
Reliability and impact of drug authentication at the point of dispensing
This report, written by the Prof Steve Simoens of the Katholieke Universiteit Leuven, documents the findings from an independent audit of Aegate's drug authentication service.
To download a copy of the summary click here
If you would like to see the full report - please email leanne.huff@aegate.com